The S-Series OCT is a disruptive technology platform that for the first time allows surgeons to visualize cellular-level disease with high resolution in excised tissue during surgery. This aids margin assessment and surgical decision-making about tissue removal in real time. The S-Series OCT has been adopted by leading hospitals nationwide. The B-Series OCT with ImgAssist AI 2.0, combines proprietary AI technology with our foundational OCT technology for use during breast conserving surgery. Pivotal trial results demonstrated super-superiority of the B-Series’ ability to aid surgeons in achieving clear surgical margins during surgery, potentially lowering the need for reoperation.